Well being expertise firm Tempus AI, established by the Groupon founder and billionaire Eric Lefkofsky, was named as a nominal defendant in a shareholder by-product lawsuit filed towards a number of firm executives in Illinois federal court docket this week. The plaintiff claims the corporate overstated its synthetic intelligence (AI) capabilities and embellished the worth of its contracts with companions, like AstraZeneca and Pathos AI, the grievance mentioned.
Trending
- The ACC Builds Around Bobbleheads for College Football Kickoff
- When Bollywood calls you ‘Param Sundari’ but your date just calls you coconut guy | Feelings News
- WordPress Trademark Applications Rejected By USPTO
- Aisin highlights safety and sustainable mobility solutions at ITS World Congress 2025
- ‘It’s definitely a common thing…’: Why GLP-1 drugs like Ozempic and Wegovy may trigger hair loss and how to minimise it, according to a dermatologist | Health News
- Inrix focuses on the future of traffic management at ITS World Congress 2025
- Bharti Singh claps back at trolls criticising her for resuming work 12 days after delivery: ‘Uncle log the saare’; psychotherapist weighs in | Lifestyle News
- West Midlands delegation begins Birmingham 2027 promotion
Thursday, August 28
AI-Backed Healthcare Company Hit with Shareholder Derivative Suit
